Notebook

Self-starting science fraud investigators Walter Stewart and Ned Feder at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) appear to have received something like an apology from their supervisor, L. Earl Laurence. Laurence had written the two men a stern reprimand concerning an incident of alleged misuse of NIDDK letterhead. After a November appearance before the federal Commission on Research Integrity--previously approved by Laurence--Stewart and Feder in January s

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Self-starting science fraud investigators Walter Stewart and Ned Feder at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) appear to have received something like an apology from their supervisor, L. Earl Laurence. Laurence had written the two men a stern reprimand concerning an incident of alleged misuse of NIDDK letterhead. After a November appearance before the federal Commission on Research Integrity--previously approved by Laurence--Stewart and Feder in January sent Kenneth Ryan, commission chairman and a professor of obstetrics, gynecology, and reproductive biology at Harvard Medical School, a copy of an unofficial report on a congressional inquiry into alleged misconduct by HIV researcher Robert C. Gallo of the National Cancer Institute. In a February 15 memorandum, Laurence called the mailing a "flagrant violation" of his April 1993 directives to the pair to cease misconduct inquiries on government time, adding in one communication, "you are not to use Government ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies